MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY — MAGIC-HF  

Heart Failure Clinical Trial

Official title: MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY (MAGIC-HF STUDY): Observational Study on Physiopathological, Diagnostic, Therapeutic, and Predictive Aspects of Heart Failure and Associated Comorbidities

Status Recruiting

Clinical Trial Summary

The MAGIC-HF STUDY project (MAgna GraecIa evaluation of Comorbidities in patients with Heart Failure STUDY), is an observational prevalence and incidence study focusing on the role that risk factors, various comorbidities, and their treatment may have on CV and non-CV outcomes in patients with all forms of HF. It also aim to assess whether comorbidities and their treatment may be predictors of response to pharmacological and non-drug treatment of HF.

Clinical Trial Description

Adult subjects with all forms of HF (HFrEF, HFmrEf, HEpEF) with at least one comorbidity who are referred to the Heart Failure Outpatient Clinic of the AOU "Mater Domini" Geriatrics Unit in Catanzaro will be recruited.

Initially, patients will be evaluated at baseline and followed-up for a minimum of six-month.

All patients will be subjected to clinical, instrumental and laboratory examinations, including medical history data collection and complete anthropometric assessment . Plasma and serum samples will be collected at recruitment and at the six-months follow-up visit. Stool samples will also be obtained and stored at -80C for the omics studies. ;

Related Conditions & MeSH terms

• Heart Failure

• NCT number: NCT05915364
• Study type: Observational
• Source: University of Catanzaro
• Contact: Angela Sciacqua, MD
• Phone: 003909613694103
• Email: sciacqua@unicz.it
• Status: Recruiting
• Start date: November 1, 2022
• Completion date: November 2024